Opinion
The vaccine system is broken – but COVID-19 shows us how to fix it
Rather than throwing money around in a crisis, governments and multilateral groups should make it more profitable for companies to tackle developing country and rare diseases all the time.
Brooke MastersThe global drive to develop COVID-19 vaccines has been a logistical and scientific triumph. From a standing start last year, seven companies outside of China are on track to deliver more than 10 billion doses in 2022, surprising many who predicted it would take years.
For some of these companies, it is also a financial bonanza. Analytics group Airfinity estimated this week total revenue next year from the jabs could reach $US124 billion ($165 billion), with three-quarters of the take going to BioNTech/Pfizer and Moderna.
Financial Times
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles